Table 2.
Elderly patients’ demographics and clinical characteristics according to outcome (AKI; n=200)
| Characteristics | Survivors (N=145) |
Nonsurvivors (N=49) |
p-Value |
|---|---|---|---|
| Age (years) | 70.7±7.78 | 71.9±8.19 | 0.34 |
| Baseline creatinine (mg/dL) | 1.07±0.56 | 1.43±0.95 | 0.007 |
| Male (%) | 75 (51.7) | 26 (53) | 0.94 |
| AKI (%) | 36 (24.7) | 18 (36.7) | 0.08 |
| KDIGO | |||
| Stage 1 | 22 (61.1) | 2 (11.1) | <0.001 |
| Stage 2 | 6 (16.7) | 3 (6.1) | 0.43 |
| Stage 3 | 8 (22.2) | 13 (72.2) | <0.001 |
| AKI etiology (%) | |||
| Prerenal | 21 (58.3) | 4 (8.2) | <0.01 |
| Renal | 15 (41.7) | 14 (77.8) | <0.01 |
| Diabetes (%) | 26 (48.1) | 52 (32.2) | 0.08 |
| Cardiovascular disease (%) | 22 (40.7) | 43 (29.5) | 0.07 |
| Sepsis (%) | 39 (26.9) | 30 (61.2) | <0.001 |
| APACHE II | 11.0±4.25 | 19.1±6.62 | <0.001 |
| ICU stay (days) | 5.9±2.8 | 11.3±5.8 | <0.001 |
| Noradrenaline use (%) | 29 (20) | 23 (46.9) | <0.001 |
| Mechanical ventilation (%) | 25 (17.2) | 21 (42.8) | 0.02 |
Abbreviations: AKI, acute kidney injury; APACHE, Acute Physiology and Chronic Health Evaluation; ICU, intensive care unit; KDIGO, Kidney Disease Improving Global Outcomes.